A survey on distribution and toxigenicity of Aspergillus flavus from indoor and outdoor hospital environments
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Aspergillus flavus classification genetics isolation & purification metabolism MeSH
- Phylogeny MeSH
- Air Microbiology * MeSH
- Molecular Sequence Data MeSH
- Mycotoxins metabolism MeSH
- Hospitals MeSH
- Soil Microbiology * MeSH
- Equipment and Supplies, Hospital microbiology MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Iran MeSH
- Names of Substances
- Mycotoxins MeSH
In the present study, genetic diversity and mycotoxin profiles of Aspergillus flavus isolated from air (indoors and outdoors), levels (surfaces), and soils of five hospitals in Southwest Iran were examined. From a total of 146 Aspergillus colonies, 63 isolates were finally identified as A. flavus by a combination of colony morphology, microscopic criteria, and mycotoxin profiles. No Aspergillus parasiticus was isolated from examined samples. Chromatographic analyses of A. flavus isolates cultured on yeast extract-sucrose broth by tip culture method showed that approximately 10% and 45% of the isolates were able to produce aflatoxin B(1) (AFB(1)) and cyclopiazonic acid (CPA), respectively. Around 40% of the isolates produced sclerotia on Czapek-Dox agar. The isolates were classified into four chemotypes based on the ability to produce AF and CPA that majority of them (55.5%) belonged to chemotype IV comprising non-mycotoxigenic isolates. Random amplified polymorphic DNA (RAPD) profiles generated by a combination of four selected primers were used to assess genetic relatedness of 16 selected toxigenic and non-toxigenic isolates. The resulting dendrogram demonstrated the formation of two separate clusters for the A. flavus comprised both mycotoxigenic and non-toxigenic isolates in a random distribution. The obtained results in this study showed that RAPD profiling is a promising and efficient tool to determine intra-specific genetic variation among A. flavus populations from hospital environments. A. flavus isolates, either toxigenic or non-toxigenic, should be considered as potential threats for hospitalized patients due to their obvious role in the etiology of nosocomial aspergillosis.
See more in PubMed
Clin Microbiol Infect. 2003 Dec;9(12):1191-202 PubMed
Clin Microbiol Infect. 2001;7 Suppl 2:38-45 PubMed
Folia Biol (Praha). 1999;45(3):97-9 PubMed
Mycopathologia. 2006 Mar;161(3):183-92 PubMed
Appl Environ Microbiol. 1999 Apr;65(4):1444-9 PubMed
Toxicol Ind Health. 2009 Oct-Nov;25(9-10):657-67 PubMed
Mycopathologia. 2009 Nov;168(5):257-68 PubMed
Int J Food Microbiol. 2007 Feb 15;113(3):330-8 PubMed
Appl Environ Microbiol. 1996 Aug;62(8):2947-52 PubMed
J Hosp Infect. 2006 Jul;63(3):246-54 PubMed
Mem Inst Oswaldo Cruz. 2007 Sep;102(6):687-92 PubMed
J Hosp Infect. 2002 Nov;52(3):185-91 PubMed
Diagn Microbiol Infect Dis. 1999 Jul;34(3):221-7 PubMed
Biosci Biotechnol Biochem. 2007 Sep;71(9):2329-32 PubMed
J Gen Microbiol. 1963 Sep;32:397-402 PubMed
J Hosp Infect. 2004 Sep;58(1):59-62 PubMed
Am J Infect Control. 2009 Apr;37(3):189-94 PubMed
Appl Environ Microbiol. 1999 May;65(5):2264-6 PubMed
Mycopathologia. 2002;153(1):41-8 PubMed
Sci Total Environ. 2010 Sep 15;408(20):4285-95 PubMed
J Clin Microbiol. 2001 Sep;39(9):3360-1 PubMed
Mycologia. 2005 Mar-Apr;97(2):425-32 PubMed
Appl Environ Microbiol. 1983 Dec;46(6):1435-7 PubMed
Genet Mol Res. 2008 Aug 05;7(3):706-17 PubMed
Appl Environ Microbiol. 1988 Aug;54(8):2096-100 PubMed
Rev Iberoam Micol. 2001 Dec;18(4):156-62 PubMed
Fungal Genet Biol. 2003 Jul;39(2):103-17 PubMed
J Clin Microbiol. 1998 Jun;36(6):1494-500 PubMed
